Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection

Journal of Hepatology

Volumn 30, Issue 2, 1999, Pages 177-184

  Zibert, Andree ^a,b   Kraas, Wolfgang ^c   Ross, R Stefan ^a   Meisel, Helga ^d   Lechner, Sabine ^a   Jung, Günther ^c   Roggendorf, Michael ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Institut für Organische Chemie   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Envelope; Epitopes; HCV; Neutralization

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CHRONIC HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0032964973     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80059-2     Document Type: Article

References (39)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science. 244:1989;359-362.
2. Alter HJ. The chronic consequences of non-A, non-B hepatitis. Seeff LB, Lewis JH, . Current Perspectives in Hepatology. 1989;83-97 Plenum, New York.
3. Simmonds P, Holmes EC, Cha T-A, Chan S-W, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 74:1993;2391-2399.
4. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 66:1992;3225-3229.
5. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, et al. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol. 68:1994;4776-4784.
6. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology. 195:1993;297-301.
7. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. PNAS. 89:1992;3468-3472.
8. Choo Q-L, Kuo G, Ralston R, Weiner AJ, Chien D, van Nest G, et al. Vaccination of chimpanzees against infection by hepatitis C virus. PNAS. 91:1994;1294-1298.
9. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. PNAS. 93:1996;1759-1763.
10. Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, et al. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet. 342:1993;435-436.
11. Höhne M, Schreier E, Roggendorf M. Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak. Arch Virol. 137:1994;25-34.
12. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology. 208:1995;653-661.
13. Zibert A, Kraas W, Meisel H, Jung G, Roggendorf M. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. J Virol. 71:1997;4123-4127.
14. Farci P, Shimoda A, Wong D, Cabezon T, DeGiovannis D, Strazzera A, et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against hypervariable region 1 of the envelope 2 protein. PNAS. 93:1996;15394-15399.
15. Zibert A, Meisel H, Kraas W, Schulz A, Jung G, Roggendorf M. Early antibody response against hypervariable region 1 is associated with acute self-limiting infection of hepatitis C virus. Hepatology. 25:1997;1245-1249.
16. Meisel H, Reip A, Faltus B, Lu M, Porst H, Wiese M, et al. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. [see comments] Lancet. 345:1995;1209-1211.
17. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 88:1991;2451-2455.
18. Lechner S, Rispeter K, Meisel H, Kraas W, Jung G, Roggendorf M, et al. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1. Virology. 243:1998;313-321.
19. Zhang ZX, Sonnerborg A, Sallberg M. Antigenic structure of the hepatitis C virus envelope 2 protein. Clin Exp Immunol. 98:1994;382-387.
20. Ray R, Khanna A, Lagging LM, Meyer K, Choo QL, Ralston R, et al. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. [published erratum appears in J Virol 1994 Sep; 68(9): 6136] J Virol. 68:1994;4420-4426.
21. Pirisi M, Ferroni P, Fabris C, Toniutto P, Soardo G, Vitulli D, et al. Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease. Infection. 23:1995;24-28.
22. Wang YF, Brotman B, Andrus L, Prince AM. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees. J Infect Dis. 173:1996;808-821.
23. Ching WM, Wychowski C, Beach MJ, Wang H, Davies CL, Carl M, et al. Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. Proc Natl Acad Sci USA. 89:1992;3190-3194.
24. Mink MA, Benichou S, Madaule P, Tiollais P, Prince AM, Inchauspe G. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology. 200:1994;246-255.
25. Chan SW, Bye JM, Jackson P, Allain JP. Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library. J Gen Virol. 77:1996;2531-2539.
26. Kurosaki M, Enomoto N, Marumo F, Sato C. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis. Virology. 205:1994;161-169.
27. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology. 197:1993;659-668.
28. Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, et al. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol. 151:1993;4189-4199.
29. Battegay M, Fikes J, Di BA, Wentworth PA, Sette A, Celis E, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol. 69:1995;2462-2470.
30. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, et al. Possible mechanism involving Tlymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancer. 346:1995;1006-1007.
31. Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA. 92:1995;2755-2759.
32. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 149:1992;3339-3344.
33. LerouxRoels G, Esquivel CA, Deleys R, Stuyver L, Elewaut A, Philippe J, et al. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Hepatology. 23:1996;8-16.
34. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. PNAS. 91:1994;7792-7796.
35. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing autibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol. 68:1994;1494-1500.
36. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet. 343:1994;388-390.
37. Laskus T, Wang LF, Rakela J, Vargas H, Pinna AD, Tsamandas AC, et al. Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology. 220:1996;171-176.
38. Thomssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol Berl. 182:1993;329-334.
39. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, et al. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol. 67:1993;1953-1958.